3-chlorotyrosine in Sputum of COPD Patients: Relationship with Airway Inflammation

REFERENCES

• The COPD guidelines group of the standards of care committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52:S1–28.
   PubMedGoogle Scholar
• Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary. Am J Respir Crit Care Med 2007; 176:532–555.
   PubMed Web of Science ®Google Scholar
• Hill AT, Campbell EJ, Bayley DL, Hill SL, Stockley RA. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med 1999; 160:1968–1975.
   PubMed Web of Science ®Google Scholar
• Riise GC, Ahlstedt S, Larsson S, Enander I, Jones I, Larsson P, Andersson B. Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax 1995; 50:360–365.
   PubMed Web of Science ®Google Scholar
• Pesci A, Balbi B, Majori M, Cacciani G, Bertacco S, Alciato P, Donner CF. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J 1998; 12:380–386.
   PubMed Web of Science ®Google Scholar
• Keatings VM, Barnes PJ. Granulocyte activation markers in induced sputum-comparison between chronic obstructive pulmonary disease, asthma and normal subjects. Am J Respir Crit Care 1997; 155:449–453.
   PubMed Web of Science ®Google Scholar
• Angrill J, Agusti C, De Celis R, Filella X, RAÑÓ A, Elena M, De La Bellacasa JP, Xaubet A, Torres A. Bronchial Inflammation and Colonization in Patients with Clinically Stable Bronchiectasis. Am. J. Respir. Crit. Care Med. 2001; 164:1628–1632.
   PubMed Web of Science ®Google Scholar
• Kettle AJ, Chan T, Osberg I, Senthilmohan R, Chapman ALP, Mocatta TJ, Wagener JS. Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis. Am J Respir Crit Care Med 2004; 170:1317–1323.
   PubMed Web of Science ®Google Scholar
• Garner HP, Phillips JR, Herron JG, Severson SJ, Milla CE, Regelmann WE. Peroxidase activity witin circulating neutrophils correlates with pulmonary phenotype in cystic fibrosis. J Lab Clin Med 2004; 144:127–133.
   PubMed Web of Science ®Google Scholar
• Cantin AM, North SL, Fells GA, Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J Clin Invest 1987; 79:1665–1673.
   PubMed Web of Science ®Google Scholar
• Lamb NJ, Gutteridge JMC, Baker C, Evans TW, Quinlan GJ. Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: Evidence for neutrophil-mediated hydroxylation, nitration and chlorination. Crit Care Med 2000; 27:1738–1744.
   Web of Science ®Google Scholar
• Buss IH, Senthilmohan R, Darlow BA, Mogridge N, Kettele AJ, Winterbourne CC. 3-chlorotyrosine as a marker of protein damage by myeloperoxidase in tracheal aspirates from preterm infants: Association with adverse respiratory outcome. Pediatric Res 2003; 53:455–462.
   PubMed Web of Science ®Google Scholar
• Hill AT, Bayley D, Stockley RA. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. Am J Respir Crit Care 1999; 160:893–898.
   PubMed Web of Science ®Google Scholar
• Stockley RA, Bayley D, Hill SL, Hill AT, Crooks S, Campbell EJ. Assessment of airway neutrophils by sputum colour: correlation with airways inflammation. Thorax. 2001; 56:366–372.
   PubMed Web of Science ®Google Scholar
• Klebanoff SJ. Oxygen metabolism and the toxic properties of phagocytes. Ann Intern Med 1980; 93:480–489.
   PubMed Web of Science ®Google Scholar
• Babior BM. NADPH oxidase: an update. Blood 1999; 93:1464–1476.
   PubMed Web of Science ®Google Scholar
• Mohammed JR, Mohammed BS, Pawluk LJ, Bucci DM, Baker NR, Davis WB. Purification and cytotoxic potential of myeloperoxidase in cystic fibrosis sputum. J Lab Clin Med 1988; 112: 711–720.
   PubMed Web of Science ®Google Scholar
• Fu S, Wang H, Davies M, Dean R. Reactions of hypochlorous acid with tyrosine and peptidyl-tyrosyl residues give dichlorinated and aldehydic products in addition to 3-chlorotyrosine. J Biol Chem 2000; 275:10851–10858.
   PubMed Web of Science ®Google Scholar
• Winterbourne CC. Biological reactivity and biomarkers of neutrophil oxidants, hypochlorus acid. Toxicol 2002; 181:223–227.
   PubMed Web of Science ®Google Scholar
• Winterbourne CC, Kettle AJ. Biomarkers of myeloperoxidase-derived hypochlorus acid. Free Rad Biol Med 2000; 29:403–409.
   PubMed Web of Science ®Google Scholar
• Saude EJ, Lacy P, Musat-Marcu S, Mayes DC, Bagu J, Man PSF, Sykes, BD, Moqbel R. NMR analysis of neutrophil activation in sputum samples from patients with cystic fibrosis. Magnet Reson Med 2004; 52:807–814.
   PubMed Web of Science ®Google Scholar
• Lamb NJ, Gutteridge JMC, Baker C, Evans TW, Quinland GJ. Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: Evidence for neutrophil-mediated hydroxylation, nitration, and chlorination. Crit Care Med 1999; 27:1738–1744.
   PubMed Web of Science ®Google Scholar
• Pennathur S, Bergt C, Shao BH, Byun J, Kassim SY, Singh P, Green PS, McDonald TO, Brunzell J, Chait A, Oram JF, O’Brien K, Geary RL, Heinecke JW. Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species. J Biol Chem 2004; 279:42877–42983.
   Google Scholar
• Wu SM, Pizzo SV. Alpha(2)-macroglobulin from rheumatoid arthritis synovial fluid: Functional analysis defines a role for oxidation in inflammation. Arch Biochem Biophys 2001; 391: 119–126.
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, McMenamin ME, Loseto G, Heinecke JW. Myeloperoxidase-catalysed 3-chlorotyrosine formation in dialysis patients. Free Rad Biol Med 2001; 31: 1163–1169.
   PubMed Web of Science ®Google Scholar
• Woolhouse IS, Bayley DL, Stockley RA. Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis. Thorax 2002; 57:667–671.
   PubMed Web of Science ®Google Scholar
• Kettle AJ, Winterbourn CC. Myeloperoxidase: a key regulator of neutrophil oxidant production. Redox. Report. 1997; 3: 3–15.
   PubMed Web of Science ®Google Scholar
• Hoy A, Leininger-Muller B, Kutter D, Siest G, Visvikis S. Growing significance of myleoperoxidase in non-infectious diseases. Clin Chem Lab Med 2002; 40:2–8.
   PubMed Web of Science ®Google Scholar
• Meyer KC. Neutrophils, myeloperoxidase, and bronchiectasis in cystic fibrosis: Green is not good. J Lab Clin Med 2004; 144:124–126.
   PubMed Web of Science ®Google Scholar
• Hazen SL, Crowley JR, Muelller DM, Heinecke JW. Mass Spectrometric quantification of 3-chlorotyrosine in human tissues with attomole sensitivity-a sensitive and specific marker for myeloperoxidase-catalyzed chlorination at sites of inflammation. Free Rad Biol Med 1997; 23:909–916.
   PubMed Web of Science ®Google Scholar
• Kettle AJ. Detection of 3-chlorotyrosine in proteins exposed to neutrophil oxidants. Meth Enzymol 1999; 300:111–120.
   PubMed Web of Science ®Google Scholar
• Crow JP. Measurement and significance of free and protein-bound 3-nitrotyrosine, 3-chloroyrosine, and free 3-nitro-4-hydroxyphenylacetic acid in biologic samples: A high-performance liquid chromatography method using electrochemical detection. Meth Enzymol 1999; 301:151–160.
   PubMed Web of Science ®Google Scholar
• Parr DG, White AJ, Bayley DL, Guest PJ, Stockley RA. Inflammation in sputum relates to progression of disease in subjects with COPD: a prospective descriptive study. Respir Res 2006; 7:136–146.
   PubMed Web of Science ®Google Scholar
• Pesci A, Balbi B, Majori M, Cacciani G, Bertacco S, Alciato P, Donner CF. Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. Eur Respir J 1998; 12:380–386.
   PubMed Web of Science ®Google Scholar
• Whiteman M, Spencer JPE. Loss of 3-chlorotyrosine by inflammatory oxidants: Implications for the use of 3-chlorotyrosine as a biomarker in vivo. Biochem Biophys Res Commun 2008; 371:50–53.
   PubMed Web of Science ®Google Scholar
• Hazen SL. Systemic marker for monitoring anti-inflammatory and anti-oxidant activity of therapeutic agents. US Patent 0180218 A1, 2003.
   Google Scholar
• Trush MA, Egner PA, Kensler TW. Myeloperoxidase as a biomarker of skin irritation and inflammation. Fd Chem Toxic 1994; 32: 143–147.
   PubMed Web of Science ®Google Scholar